^
BIOMARKER:

EGFR mutation + EGFR T790M

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR mutation + EGFR T790M
NSCLC
afatinib + osimertinib
Sensitive: C3 – Early Trials
Lung Cancer - 3 weeks
EGFR mutation + EGFR T790M
NSCLC
osimertinib
Resistant: C3 – Early Trials